Exhibit 10.01


 


EMPLOYMENT AGREEMENT


 


THIS EMPLOYMENT AGREEMENT
(the “Agreement”) is dated as of April 1, 2012, between Tonix Pharmaceuticals Holding Corp., a Nevada corporation
(the “Company”), and Leland Gershell (the “Executive”).


 


In consideration of
the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:


 


Section
1.  Employment.


 


The Company agrees
to employ the Executive in the position of Chief Financial Officer with the Company, and Executive agrees to render such services
to the Company upon the terms and conditions hereinafter set forth commencing on April 1, 2012 (the “Agreement Effective
Date”).


 


Section
2.  At-Will Employment. 


 


The Executive’s
employment by the Company is on an at-will basis and, therefore, may be terminated at any time with or without notice and with
or without cause. It is understood, however, that absent unusual circumstances, the Executive will provide at least two weeks notice
of an intent to terminate the employment relationship, as will the Company. Except as expressly provided herein, the Executive
shall, upon termination, be entitled to no further compensation other than earned salary Base Salary (as defined below) through
his last day of active employment.


 


Section
3.  Position and Duties.


 


(a)    During the Employment
Period, the Executive shall serve as the Chief Financial Officer of the Company. The Executive shall have such duties and responsibilities
as are typically performed by a Chief Financial Officer of a public company and as may be assigned to him from time to time by
the President and/or the Board of Directors of the Company (the “Board”).


 


(b)    The Executive
shall report to the President of the Company and shall devote his best efforts and substantially all of his active business time
and attention (except for permitted vacation periods and reasonable periods of illness or other incapacity) on a full-time basis
to the business and affairs of the Company and its affiliates. The Executive shall perform his duties and responsibilities to the
best of his abilities in a diligent and professional manner. The Executive shall perform his duties principally at the Company’s
offices in New York City, and, to the extent reasonably requested by the President or the Board, shall provide services as needed
at the Company’s other offices. During the Employment Period, the Executive shall not engage in any outside business activity
without the prior written approval of the Board, whether or not such activity is pursued for gain, profit or other pecuniary advantage.


 



    	 



    	 



    

 


(c)    The foregoing
restrictions shall not limit or prohibit the Executive from engaging in passive investment, and community, charitable and social
activities not interfering with the Executive’s performance and obligations hereunder.


 


Section
4.  Base Salary


 


(a)    From
the Agreement Effective Date to the date on which the Company consummates the sale of at least Twenty Million Dollars ($20,000,000)
in additional equity securities (the “Financing”) the Executive’s base salary shall be one hundred seventy
five thousand dollars ($175,000) per annum.


 


(b)    In
the event, and upon the consummation, of the Financing, the Executive’s base salary shall
be increased to Three Hundred Twenty-Five Thousand Dollars ($325,000) per annum, or such other higher rate at such time or thereafter
as the Board may designate from time to time.


 


(c)    The
Executive may be eligible to earn annual bonuses as shall be determined by the Board in its sole discretion based upon the Executive’s
performance and the financial performance of the Company. The Board shall determine the amount of each such annual bonus, if any,
promptly following the close of the calendar year and shall pay such bonus by no later than March 15th of the year immediately
following the year in which the bonus was earned.


 


(d)    The
Executive shall be permitted during the term of this Agreement, if and to the extent eligible, to participate in all employee benefit
plans, policies and practices now or hereafter maintained by or on behalf of the Company commensurate with the Executive’s
position with the Company. Nothing in this Agreement shall preclude the Company from terminating or amending any such plans or
coverage so as to eliminate, reduce or otherwise change any benefit payable thereunder to the extent permissible under the terms
of the plan.


 


(e)    The
Company shall, in accordance with policies then in effect with respect to payments of business expenses, pay or reimburse the Executive
for all reasonable out-of-pocket business expenses actually incurred by the Executive during the Employment Period in performing
services hereunder; provided, however that to the extent required to comply with the provisions of Section 409A (“Code
Section 409A”) of the Internal Revenue Code of 1986, as amended (the “Code”), (1) no reimbursement
of expenses incurred by the Executive during any taxable year shall be made after the last day of the following taxable year of
the Executive, (2) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a taxable year of the
Executive shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, to the Executive in any
other taxable year, and (3) the right to reimbursement of such expenses shall not be subject to liquidation or exchange for another
benefit. All expenses shall be accounted for in such reasonable detail as the Company may require.


 



    	2



    	 



    

 


(f)    During
the Employment Period, the Executive shall be entitled to twenty (20) vacation days per year, as well as holidays, sick days and
personal days in accordance with the Company’s policies, as such policies may be amended from time to time. The Executive
may not carry forward any unused vacation, holiday, sick or personal days into subsequent years.


 


Section
5.  Termination.


 


(a)    Termination
upon Death. If the Executive dies during the term of this Agreement, this Agreement shall terminate as of the date of his death.


 


(b)    Termination
upon Disability. If after the Agreement Effective Date the Executive becomes physically or mentally disabled, whether totally
or partially, so that the Executive is unable to perform his essential job functions for a period aggregating 120 consecutive days
during any twelve month period, and it is determined by a physician reasonably acceptable to both the Company and the Executive
that, by reason of such physical or mental disability, the Executive shall be unable to perform the essential job functions required
of him for such period or periods, the Company may, by written notice to the Executive, terminate this Employment Agreement, in
which event such termination shall be effective thirty (30) days after the date upon which the Company shall have given notice
to the Executive of its intention to terminate this Agreement.


 


(c)    Termination
for Cause. The Company may at any time by written notice to the Executive terminate this Agreement for “Cause”
and the Executive shall have no right to receive any compensation or benefit hereunder on and after the date of such notice. For
purposes of this Agreement “Cause” shall include


 


(1)    the failure by
the Executive to perform such duties as are within the scope of this Agreement and as are reasonably requested in good faith by
the President or the Board in the course of the Executive’s performance of his duties hereunder;


 


(2)    gross negligence,
recklessness or willful misconduct by the Executive in the performance of his duties;


 


(3)    a conviction of
or a plea of guilty or nolo contendere by the Executive to a crime involving fraud, embezzlement, theft, other financial dishonesty
or moral turpitude;


 


(4)    the material breach
by the Executive of this Agreement or of any other agreement or contract with the Company, or any of its affiliates; or


 


(5)    the Board’s
reasonable determination that the Executive has engaged in a violation of state or federal law relating to the workplace environment
(including, without limitation, laws relating to sexual harassment or age, sex or other prohibited discrimination).


 


(d)    Termination
without Cause. The Company may terminate this Employment Agreement at any time without Cause, upon written notice by the Company
to the Executive and, except as provided in Sections 6(a) and (b) hereof, the Executive shall have no right to receive any compensation
or benefit hereunder after the effective date of such termination.


 



    	3



    	 



    

 


Section
6.  Severance Payments


 


(a)    
If Company terminates this Agreement other than for Cause as defined in Section 5(c) before consummation of the Financing,
Executive shall continue to receive his Base Salary for the six (6) week period following such termination, payable in accordance
with Company’s normal payroll practices.


 


(b)    If
Company terminates this Agreement other than for Cause as defined in Section 5(c) after consummation of the Financing, Executive
shall continue to receive his Base Salary for the six (6) month period following such termination, payable in accordance with Company’s
normal payroll practices.


 


(c)    Compliance
With Code Section 409A. Notwithstanding anything herein to the contrary, this Agreement is intended to be interpreted and shall
operate so that the payments and benefits set forth herein either shall be exempt from the requirements of Code Section 409A or
shall comply with the requirements of such provision; provided, however, that in no event shall the Company be liable to the Executive
for or with respect to any taxes, penalties or interest which may be imposed upon the Executive pursuant to Code Section 409A.
For purposes of this Agreement, the terms “termination,” “termination of employment” and variations thereof
shall mean a “separation from service” as defined in Treasury Regulation Section 1.409A-1(h) (“Separation
From Service”). To the extent that any Severance payment constitutes a “deferral of compensation” subject
to Code Section 409A (a “409A Payment”), then, (A) in the event that a termination of Executive’s employment
does not constitute a Separation From Service, such 409A Payment shall begin at such time as the Executive has otherwise experienced
such a Separation from Service, and the date of such Separation from Service shall be deemed to be his termination date for purposes
of Section 4(a) hereof, and (B) if on the date of the Executive’s Separation from Service, the Executive is a “specified
employee” of a public company, as such term is defined in Treasury Regulation Section 1.409A-l(i), as determined from time
to time by the Company, then such 409A Payment shall not be made to the Executive until the earlier of six (6) months and one day
after the Executive’s Separation from Service and shall be paid without adjustment for the delay in payment. The Executive
hereby acknowledges that he has been advised to seek and has sought the advice of a tax advisor with respect to the tax consequences
to the Executive of all payments pursuant to this Agreement, including any adverse tax consequences or penalty taxes under Code
Section 409A and applicable state tax law. The Executive hereby agrees to bear the entire risk of any such adverse federal and
state tax consequences and penalty taxes in the event any payment pursuant to this Agreement is deemed to be subject to Code Section
409A, and that no representations have been made to the Executive relating to the tax treatment of any payment pursuant to this
Agreement under Code Section 409A and the corresponding provisions of any applicable state income tax laws.


 


(d)    Notwithstanding
the foregoing, all payments and obligations of the Company under this Section 6 shall be conditioned upon the execution and delivery
by Executive to the Company of a full and effective release by Executive of any liability by the Company to Executive in form and
substance reasonably satisfactory to the Company.


 



    	4



    	 



    

 


Section
7.  Nondisclosure and Nonuse of Confidential Information.


 


(a)    The
Executive shall not disclose or use at any time without the written consent of the Company, either during the Employment Period
or thereafter, any Confidential Information (as defined below) of which the Executive is or becomes aware, whether or not such
information is developed by him, except to the extent that such disclosure or use is directly related to and required by the Executive’s
performance in good faith of duties assigned to the Executive by the Company or is required to be disclosed by law, court order,
or similar compulsion; provided, however, that such disclosure shall be limited to the extent so required or compelled; and provided,
further, that the Executive shall give the Company notice of such disclosure and cooperate with the Company in seeking suitable
protection. The Executive acknowledges that the Company’s Confidential Information has been generated at great effort and
expense by the Company and its predecessors and affiliates and has been maintained in a confidential manner by the Company, its
predecessors and affiliates. The Executive does not claim any rights to or lien on any Confidential Information. The Executive
will immediately notify the Company of any unauthorized possession, use, disclosure, copying, removal or destruction, or attempt
thereof, of any Confidential Information by anyone of which the Executive becomes aware and of all details thereof. The Executive
shall take all reasonably appropriate steps to safeguard Confidential Information and to protect it against disclosure, misuse,
espionage, loss and theft. The Executive shall deliver to the Company on the day this Agreement is terminated, or at any time the
Company may request, all memoranda, notes, plans, records, reports, computer tapes and software and other documents and data (and
copies thereof regardless of the form thereof (including electronic and optical copies)) relating to the Confidential Information
or the Work Product (as defined below) of the Company or any of its affiliates which the Executive may then possess or have under
his control.


 


(b)    As
used in this Agreement, the term “Confidential Information” means information that is not generally known to the public
and that is used, developed or obtained by the Company or any affiliate in connection with its business, including, but not limited
to, information, observations and data obtained by the Executive while employed by the Company or any predecessors thereof (including
those obtained prior to the date hereof) concerning (i) the business or affairs of the Company (or such predecessors), (ii) technologies,
products or services, (iii) data, test results, designs, methods, formulae, production methods, know-how, show-how, techniques,
systems, processes, specifications, drawings, reports, software programs, works of authorship, research and development, (iv) inventions,
new developments and trade secrets, whether patentable or unpatentable and whether or not reduced to practice, (v) existing and
prospective licensors, licensees, partners, customers, clients, contractors and suppliers, (vi) agreements with licensees, licensors,
partners, customers, clients, contractors, suppliers and other entities or individuals, (vii) projects, plans and proposals, (vii)
fees, costs and pricing structures, (viii) accounting and business methods, (ix) business strategies, acquisition plans and candidates,
financial or other performance data and personnel lists and data, and (x) all similar and related information in whatever form,
unless the information is or becomes publicly known through lawful means.


 



    	5



    	 



    

 


Section
8.      Inventions and Patents.


 


(a)    The
Executive agrees that all inventions, ideas, innovations, improvements, modifications, data, test results, technical information,
systems, software developments, methods, designs, analyses, drawings, reports, service marks, trademarks, trade names, logos and
all similar or related information (whether patentable or unpatentable) which relate to the Company’s or any of its affiliates’
actual or anticipated business, research and development or existing or future products or services and which are conceived, developed
or made by the Executive (whether or not during usual business hours or on the premises of the Company or any affiliate and whether
or not alone or in conjunction with any other person) while employed by the Company (including those conceived, developed or made
prior to the date of this Agreement), or results from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted by the Company, together with all patent applications, letters patent, trademark, tradename and service
mark applications or registrations, copyrights, reissues thereof and any other legal protection thereon that may be granted for
or upon any of the foregoing (collectively referred to herein as the “Work Product”), belong in all instances
exclusively to the Company or such affiliate as works made for hire or otherwise to the fullest extent permitted by applicable
law. The Executive will keep and maintain adequate and current written records of all Work Product made by him (in the form of
notes, sketches, drawing and other records as may be specified by the Company), which records shall be available to and remain
the sole property of the Company at all times. The Executive shall promptly disclose such Work Product to the President and perform
all actions reasonably requested by the President (whether during or after the Employment Period) to establish and confirm the
Company’s sole ownership of such Work Product (including, without limitation, the execution and delivery of assignments,
consents, powers of attorney and other instruments) and provide reasonable assistance to the Company or any of its affiliates in
connection with (a) the prosecution of any applications for patents, trademarks, trade names, service marks, reissues thereof or
other legal protection thereon, (b) the maintenance, enforcement and renewal of any rights that may be obtained, granted or vest
therein, and (c) the prosecution and defense of any actions, proceedings, oppositions or interferences relating thereto. If the
Company is unable, after reasonable effort, to secure the signature of the Executive on any such papers, any executive officer
of the Company shall be entitled to execute any such papers as the agent and the attorney-in-fact of the Executive, and the Executive
hereby irrevocably designates and appoints each executive officer of the Company as his or her agent and attorney-in-fact to execute
any such papers on his or her behalf, and to take any and all actions as the Company may deem necessary or desirable in order to
protect its rights and interests in any Work Product, under the conditions described in this sentence.


 


(b)    The
Executive agrees that he shall not incorporate into any Work Product any discovery, process, design, software code, technology,
device, trade secret, improvement in any of the forgoing or other ideas, whether or not patentable and whether or not reduced to
practice, made or conceived by him (whether solely or jointly with others) that does not result from any work performed by him
for the Company or which he made prior to his employment by the Company (“Other Inventions”). Executive agrees to notify
the Company in writing before he makes any disclosure or performs work on behalf of the Company that appears to threaten or conflict
with Other Inventions.


 



    	6



    	 



    

 


(c)    In
addition to damages and any other rights the Company may have, the Company shall have the right to obtain injunctive or other equitable
relief to restrain any breach or threatened breach or otherwise to specifically enforce the provisions of Section 8 of this Agreement,
it being agreed that money damages alone would be inadequate to compensate the Company and would be an inadequate remedy for such
breach. The rights and remedies of the parties to this Agreement are cumulative and not alternative.


 


Section
9.  Non-Compete; Non-Solicitation; Non-Disparagement.


 


(a)    The
Executive acknowledges that, in the course of employment with the Company and/or its affiliates, he has and will become familiar
with the Company’s and its predecessors and affiliates’ trade secrets and with other confidential information concerning
the Company and its predecessors and affiliates and that his services have been and will be of special, unique and extraordinary
value to the Company and its affiliates. Therefore, in order to protect the Company’s interest in its Confidential Information,
the Executive agrees that during the Employment Period and for one (1) year thereafter (collectively, the “Non-Compete
Period,” subject to automatic extension during the period of any violation of this Section 9), he shall not directly
or indirectly own, manage, control, participate in, consult with, render services for, or in any manner engage in or represent
any business competing with the development, marketing, and/or sale of drugs intended for use in the treatment of attention deficit
disorder, attention deficit and hyperactivity disorder, headaches, primary insomnia disorder, fibromyalgia, post-traumatic stress
disorder or any other products and/or services of the Company or its affiliates that exist or are in the process of being developed,
formed or acquired as of the date the Agreement is terminated (the “Business”), within any Restricted Territory.
As used in this Agreement, the term “Restricted Territory” means (i) the United States and (ii) any other country
or territory in which the Company has engaged in, or is engaging in, the Business as of the date the Agreement is terminated. Nothing
herein shall be construed to prevent the Executive from participating in and completing all necessary activities required to maintain
the Executive’s professional standards.


 


Nothing herein shall
prohibit the Executive from being a passive owner of not more than one percent (1%) of the outstanding stock of any class of a
corporation which is publicly traded that is engaged in the Business, so long as the Executive has no active participation in the
business of such corporation.


 


(b)    During
the Non-Compete Period, the Executive shall not directly or indirectly through another person or entity:


 


(i)    induce or attempt
to induce any employee of the Company or any affiliate to leave the employ of the Company or such affiliate, or in any way interfere
with the relationship between the Company or any such affiliate, on the one hand, and any employee thereof, on the other hand;


 



    	7



    	 



    

 


(ii)    solicit for hire
or hire any person who was an employee of the Company or any affiliate until six (6) months after such individual’s employment
relationship with the Company or any affiliate has been terminated, provided that the Executive may hire any such person (so long
as such person is not a supervisor, manager or executive officer of the Company or any affiliate) who responds to a general advertisement
offering employment;


 


(iii)    solicit, induce
or attempt to solicit or induce any customer (it being understood that the term “customer” as used throughout this
Agreement includes any Person (x) that is purchasing goods or receiving services from the Company and/or any affiliates or (y)
that is directly or indirectly providing or referring customers to, or otherwise providing or referring business for, the Company
or any affiliates), supplier, licensee, subcontractor or other business relation of the Company or any affiliate to cease or reduce
doing business with the Company or such affiliate, or in any way interfere or attempt to interfere with the relationship between
any such customer, supplier, licensee, subcontractor or business relation, on the one hand, and the Company or any such affiliate,
on the other hand; or


 


(iv)    induce or attempt
to induce any customer, supplier, licensee, subcontractor or other business relation of the Company or affiliate to purchase services
or goods similar to those sold as part of the Business.


 


(c)      The
Executive understands that the foregoing restrictions may limit his ability to earn a livelihood in a business similar to the Business,
but he nevertheless believes that he has received and will receive sufficient consideration and other benefits as an employee of
the Company and as otherwise provided hereunder to clearly justify such restrictions which, in any event (given his education,
skills and ability), the Executive does not believe would prevent him from otherwise earning a living. The Executive further understands
that (i) the parties would not enter into this Agreement but for the covenants contained in this Section 9, and (ii) the provisions
of Sections 7 through 9 are reasonable and necessary to preserve the legitimate business interests of the Company and affiliates.


 


(d)      The
Executive shall inform any prospective or future employer of any and all restrictions contained in this Agreement and provide such
employer with a copy of such restrictions (but no other terms of this Agreement), prior to the commencement of that employment.


 


(e)      The
Executive agrees that the restrictions are reasonable and necessary, are valid and enforceable under New York law, and do not impose
a greater restraint than necessary to protect the Company’s legitimate business interests. If, at the time of enforcement
of Sections 7 through 9, a court holds that the restrictions stated herein are unreasonable under the circumstances then existing,
the Executive and the Company agree that the maximum period, scope or geographical area reasonable under such circumstances shall
be substituted for the stated period, scope or area so as to protect the Company to the greatest extent possible under applicable
law.


 



    	8



    	 



    

 


(f)    In
order to protect the goodwill of the Company and its affiliates, to the fullest extent permitted by law, the Executive, both during
and after the Employment Period, agrees not to publicly criticize, denigrate, or otherwise disparage any of the Company, its affiliates,
and each such entity’s employees, officers, directors, licensees, partners, consultants, other service providers, products,
processes, policies, practices, standards of business conduct, or areas or techniques of research, development, manufacturing,
or marketing. Nothing in this Section 9(f) shall prevent the Executive or the Company from cooperating in any governmental proceeding
or from providing truthful testimony pursuant to a legally-issued subpoena. The Executive promises to provide the Company with
written notice of any request to so cooperate or provide testimony within one (1) day of being requested to do so, along with a
copy of any such request.


 


(g)    In
addition to damages and any other rights the Company may have, the Company shall have the right to obtain injunctive or other equitable
relief to restrain any breach or threatened breach or otherwise to specifically enforce the provisions of Section 9 of this Agreement,
it being agreed that money damages alone would be inadequate to compensate the Company and would be an inadequate remedy for such
breach. The rights and remedies of the parties to this Agreement are cumulative and not alternative.


 


(h)    In
addition to the foregoing, and not in any way in limitation thereof, or in limitation of any right or remedy otherwise available
to the Company, if the Executive violates any provision of the foregoing Sections 7 through 9, any Severance payments then or thereafter
due from the Company to the Executive pursuant to Section 6 shall be terminated forthwith and the Company’s obligation to
pay and the Executive’s right to receive such Severance payments shall terminate and be of no further force or effect, if
and when determined by a court of competent jurisdiction, in each case without limiting or affecting the Executive’s obligations
(or terminating the Non-Compete Period) under such Sections 7 through 9, or the Company’s other rights and remedies available
at law or equity.


 


Section
10.  Representations, Warranties and Additional Covenants of the Executive.


 


The Executive hereby
represents and warrants to the Company that (a) the execution, delivery and performance of this Agreement by the Executive does
not and shall not conflict with, breach, violate or cause a default under any agreement, contract or instrument to which the Executive
is a party or any judgment, order or decree to which the Executive is subject, (b) the Executive is not a party to or bound by
any employment agreement, (c) the Executive is not a party to or bound by any consulting agreement, non-compete agreement, confidentiality
agreement or similar agreement with any other person or entity that would affect the Company or the obligations of the Executive
hereunder and (d) upon the execution and delivery of this Agreement by the Company and the Executive, this Agreement will be a
valid and binding obligation of the Executive, enforceable in accordance with its terms. The Executive further represents and warrants
that he has not disclosed, revealed or transferred to any third party any of the Confidential Information that he may have previously
obtained and that he has safeguarded and maintained the secrecy of the Confidentiality Information to which he has had access or
of which he has knowledge. In addition, the Executive represents and warrants that he has no ownership in nor any right to nor
title in any of the Confidential Information and the Work Product.


 



    	9



    	 



    

 


Section
11.   Notices.


 


All notices, requests,
demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim or other communication
hereunder shall be deemed duly given when delivered personally to the recipient, telecopied to the intended recipient at the telecopy
number set forth therefor below, or one (1) business day after deposit with a nationally recognized overnight delivery service,
in each case as follows:


 


If to the Company, to:


 


Tonix Pharmaceuticals
Holding Corp.


509 Madison Avenue,
Suite 306


New York, New York
10022


Attention: President


 


If to the Executive, to the address set
forth on the signature page hereto; or such other address as the recipient party to whom notice is to be given may have furnished
to the other party in writing in accordance herewith. Any such communication shall deemed to have been delivered and received (a)
when delivered, if personally delivered, sent by telecopier or sent by overnight courier, and (b) on the fifth business day following
the date posted, if sent by mail. Instructions, notices or requests may be sent by email to the Executive.


 


Section
12.   General Provisions.


 


(a)    Severability.
It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular
provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of
this Agreement or affecting the validity or enforceability of this Agreement or affecting the validity or enforceability of such
provision in any other jurisdiction. Notwithstanding the foregoing and except to the extent otherwise provided in Section 9(e)
(with respect to a breach of the provisions of Section 8), if such provision could be more narrowly drawn so as not to be invalid,
prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating
the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.


 


(b)    Complete
Agreement. This Agreement constitutes the entire agreement among the parties and supersedes any prior correspondence or documents
evidencing negotiations between the parties, whether written or oral, and any and all understandings, agreements or representations
by or among the parties, whether written or oral, that may have related in any way to the subject matter of this Agreement.


 



    	10



    	 



    

 


(c)    Successors
and Assigns. Except as otherwise provided herein, this Agreement shall bind and inure to the benefit of and be enforceable
by the Executive and the Company and their respective successors, assigns, heirs, representatives and estate; provided, however,
that the rights and obligations of the Executive under this Agreement shall not be assigned without the prior written consent of
the Company in its sole discretion. The Company may (i) assign any or all of its respective rights and interests hereunder to one
or more of its affiliates, (ii) designate one or more of its affiliates to perform its respective obligations hereunder (in any
or all of which cases the Company nonetheless shall remain responsible for the performance of all of their obligations hereunder),
(iii) collaterally assign any or all of its respective rights and interests hereunder to one or more lenders of the Company or
its affiliates, (iv) assign its respective rights hereunder in connection with the sale of all or substantially all of its business
or assets (whether by merger, sale of stock or assets, recapitalization or otherwise) and (v) merge any of affiliates with or into
the Company (or vice versa). The rights of the Company hereunder are enforceable by its affiliates, who are the intended third
party beneficiaries hereof.


 


(d)    Governing
Law. This Agreement shall be governed by, and construed in accordance with and subject to, the laws of the State of New York
applicable to agreements made and to be performed entirely within such state without regard to its conflicts of law rules.


 


(e)    Jurisdiction
and Venue.


 


(i)    The Company and
the Executive hereby irrevocably and unconditionally submit, for themselves and their property, to the exclusive jurisdiction of
any New York State court or federal court of the United States of America sitting in the State of New York and any appellate court
from any thereof, in any action or proceeding arising out of or relating to this Agreement or for recognition or enforcement of
any judgment, and the Company and the Executive hereby irrevocably and unconditionally agree that all claims in respect of any
such action or proceeding may be heard and determined in any such New York State court or, to the extent permitted by law, in such
federal court. The Company and the Executive irrevocably waive, to the fullest extent permitted by law, the defense of an inconvenient
forum to the maintenance of such action or proceeding in any such court. The Company and the Executive agree that a final judgment
in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any
other manner provided by law. The Executive agrees not to commence a claim or proceeding hereunder in a court other than a New
York State court or federal court located in the State of New York, except if the Executive has first brought such claim or proceeding
in such New York State court or federal court located in the State of New York, and such court or courts have denied jurisdiction
over such claim or proceeding.


 


(ii)    The Company and
the Executive irrevocably and unconditionally waive, to the fullest extent they may legally and effectively do so, any objection
that they may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this
Agreement in any New York State court or federal court of the United States of America sitting in the State of New York and any
appellate court from any thereof.


 



    	11



    	 



    

 


(iii)    The parties
further agree that the mailing by certified or registered mail, return receipt requested to both (x) the other party and (y) counsel
for the other party (or such substitute counsel as such party may have given written notice of prior to the date of such mailing),
of any process required by any such court shall constitute valid and lawful service of process against them, without the necessity
for service by any other means provided by law. Notwithstanding the foregoing, if and to the extent that a court holds such means
to be unenforceable, each of the parties’ respective counsel (as referred to above) shall be deemed to have been designated
agent for service of process on behalf of its respective client, and any service upon such respective counsel effected in a manner
which is permitted by New York law shall constitute valid and lawful service of process against the applicable party.


 


(f)    Amendment
and Waiver. The provisions of this Agreement may be amended and waived only with the prior written consent of the Company and
the Executive, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity,
binding effect or enforceability of this Agreement or any provision hereof.


 


(g)    Headings.
The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.


 


(h)    Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together
shall constitute one and the same instrument.


 


(i)    WAIVER
OF JURY TRIAL. NO PARTY TO THIS AGREEMENT OR ANY ASSIGNEE, SUCCESSOR, HEIR OR PERSONAL REPRESENTATIVE OF A PARTY SHALL SEEK A JURY
TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON OR ARISING OUT OF THIS AGREEMENT OR
ANY OF THE OTHER AGREEMENTS OR THE DEALINGS OR THE RELATIONSHIP BETWEEN THE PARTIES.


 


* * * *


 


[Signature Page Follows]


 



    	12



    	 



    

 


IN WITNESS WHEREOF, the parties hereto have
executed this Employment Agreement as of the date first written above.


 


	TONIX PHARMACEUTICALS HOLDING CORP.
	 
	By:	/s/ SETH LEDERMAN
	 	Seth Lederman, M.D.
	 	President and Chairman
	 
	EXECUTIVE:
	 
	/s/ LELAND GERSHELL
	Leland Gershell
	 
	Address: